Stock Events

Stock Events

XOMA Royalty 

$41.66
69
+$0.62+1.51% Tuesday 20:00

Statistics

Day High
41.75
Day Low
41.08
52W High
41.97
52W Low
22.89
Volume
196,646
Avg. Volume
-
Mkt Cap
515.88M
P/E Ratio
28.3
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
Next
-0.29
0.04
0.37
0.7
Expected EPS
0.214033
Actual EPS
N/A

Financials

-48.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
56.97MRevenue
-27.64MNet Income

Analyst Ratings

55Average Price Target
The highest estimate is 76.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XOMA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the biotechnology industry focusing on developing and commercializing medicines for serious medical conditions, similar to XOMA's focus on antibody-based therapeutics.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biopharmaceutical company that discovers, develops, manufactures, and delivers innovative human therapeutics, competing directly with XOMA in the biotech sector.
Biogen
BIIB
Mkt Cap27.62B
Biogen competes with XOMA in the biotechnology field, focusing on developing therapies for neurological and neurodegenerative diseases.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas similar to XOMA, making them direct competitors.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals is involved in creating new possibilities in medicine to cure diseases and improve people's lives, competing with XOMA in the biotech innovation space.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with XOMA in the development of novel therapeutics.
Incyte
INCY
Mkt Cap19.36B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, making it a competitor in the biopharmaceutical space alongside XOMA.
Nektar Therapeutics
NKTR
Mkt Cap2.92B
Nektar Therapeutics is involved in developing new treatment options in various therapeutic areas, competing with XOMA in the innovation of biologic drugs.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical focuses on developing and commercializing innovative biopharmaceuticals for rare diseases, competing with XOMA in targeting niche markets with specialized treatments.

About

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Owen P. Hughes Jr.
Employees
13
Country
Bermuda
ISIN
US98419J2069

Listings

F
DE
X0M1.F
MU
DE
X0M1.MU
F
DE
X0M.F
BOATS
BOATS
XOMAO.BOATS

0 Comments

Share your thoughts

FAQ

What is XOMA Royalty stock price today?▼
The current price of XOMA is $41.66 USD — it has increased by +1.51% in the past 24 hours. Watch XOMA Royalty stock price performance more closely on the chart.
What is XOMA Royalty stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XOMA Royalty stocks are traded under the ticker XOMA.
Is XOMA Royalty stock price growing?▼
XOMA stock has risen by +1.63% compared to the previous week, the month change is a +23.44% rise, over the last year XOMA Royalty has showed a +80.82% increase.
What is XOMA Royalty market cap?▼
Today XOMA Royalty has the market capitalization of 515.88M
When is the next XOMA Royalty earnings date?▼
XOMA Royalty is going to release the next earnings report on July 30, 2026.
What is XOMA Royalty revenue for the last year?▼
XOMA Royalty revenue for the last year amounts to 56.97M USD.
What is XOMA Royalty net income for the last year?▼
XOMA net income for the last year is -27.64M USD.
How many employees does XOMA Royalty have?▼
As of May 06, 2026, the company has 13 employees.
In which sector is XOMA Royalty located?▼
XOMA Royalty operates in the Health & Wellness sector.
When did XOMA Royalty complete a stock split?▼
The last stock split for XOMA Royalty was on October 18, 2016 with a ratio of 1:20.
Where is XOMA Royalty headquartered?▼
XOMA Royalty is headquartered in EmeryVille, Bermuda.